Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 825 results for "gsk consumer"

Glaxo to hold onto consumer healthcare division

Contrary to a Financial Times report , GlaxoSmithKline ( GSK -0.8% ) says that it has no plans to spin off its consumer healthcare division according to Bloomberg . It is proceeding with a JV with Novartis ( NVS -0.8% ) to create a consumer health ... Seeking Alpha, 2 days ago
[x]  

57 images for gsk consumer

Pharma Letter, 2 days ago
Citywire Money, 2 days ago
Pharma Letter, 2 days ago
CNBC, 2 days ago
Orange UK, 2 days ago
CNBC, 5 days ago
SearchBug, 2 weeks ago
Yahoo! News, 2 weeks ago
Livemint.com, 1 month ago
PR Newswire, 2 weeks ago
Invezz

Don't get too excited, investors: GSK has no near-term plans for consumer health spinoff

Let GlaxoSmithKline ($GSK) be clear: It's open to spinning off its consumer healthcare division at some nebulous point in the future. But it's not happening anytime soon. The pharma giant has no plans to divest the unit--newly bolstered as part of ...
 FiercePharma1 day ago GSK Open To Consumer Division Spinoff If Good Opportunity Presents Itself: CEO  Bidness Etc2 days ago GSK share price: CEO raises possibility of break-up  Invezz2 days ago Dont get too excited investors GSK has no near-term plans for consumer health spinoff  Big News Network1 day ago

Stocks in news: ONGC, Crompton, DLF, Voltas, Tata Motors

ONGC | Crompton Greaves | Power Grid | Tata Power | Cipla | DLF | Voltas | Tata Motors | BHEL | GSK Consumer | Mcnally Bharat | Jet Airways | YES Bank | LT | MM | Suzlon Energy and Aurobindo Pharma are stocks, which are in the news today.
 Money Control2 months ago
Business Standard

GSK Consumer fined for overcharging

The company has paid Rs 48 cr in fine to NPPA for overcharging for its Crocin Advance fever and pain-relief pill Sushmi Dey | New Delhi May 28, 2014 Last Updated at 00:26 IST GlaxoSmithKline Consumer Healthcare has paid Rs 48 crore in fine to the National ...
 Business Standard2 months ago
Business Standard

Our focus on science helps retain customers: Zubair Ahmed

Interview with Managing Director, GSK Consumer Healthcare Viveat Susan Pinto | Mumbai May 13, 2014 Last Updated at 00:48 IST As multinational consumer goods companies struggle, the consumer health care arm of British drug major GlaxoSmithKline posted 15 per ...
 Business Standard2 months ago

Q4 earnings preview: Ranbaxy, GSK consumer

Angel Broking has come out with earnings preview report for companies whose results are expected today. The highlights of the report are as follows: Ranbaxy labs: ''Ranbaxy is expected to post a growth of 8.9% with sales at Rs 26.57 billion during 5QFY2014.
 Myiris2 months ago
CNBC

EXCLUSIVE-Allegations of GSK corruption spread to Syria

* Email lists alleged bribes to push GSK consumer products * GSK plans thorough investigation of allegations * GSK already faces bribery claims in five other countries * U.S. and British authorities probing drugmaker LONDON, July 24 ...
 CNBC6 days ago Despite strains, GlaxoSmithKline dividend seen safe for now  Yahoo! Finance1 day ago Add Syria To The List: Whistleblower Alleges GSK Corruption  Bidness Etc5 days ago GSK corruption scandal spreads to Syria  CNBC5 days ago
[x]  

GSK Boss Says Pharma Giant May Be Split Up

Drugs giant GlaxoSmithKline (GSK) has revealed a possible spin-off of its consumer healthcare division. Chief executive Sir Andrew Witty said the carve up may occur if it offered more value as a standalone company. It comes following an ...
 Yahoo! UK and Ireland2 days ago GSK chief Andrew Witty raises possibility of break-up  Yahoo! UK and Ireland2 days ago GSK says not to spin off consumer health business  PredictWallStreet1 day ago GSK Has Option To Separate Its Consumer Healthcare Business: FT  RTTNews.com2 days ago
[x]  
Pharma Letter

Reckitt Benckiser to spin out pharma; GSK views Consumer options

UK-based consumer goods giant Reckitt Benckiser (LSE: RB) plans to spin off its USA-based pharmaceutical business, the company announced along with its half-year 2014 financial results. Reckitt Benckiser's chief executive Rakesh Kapoor said: "We ...
 Pharma Letter2 days ago RECKITT BENCKISER : set to float US arm RB Pharmaceuticals  4 Traders2 days ago Reckitt Benckiser to spin off Pharma division as it pushes ahead with refocus on consumer health and hygiene  This is Money2 days ago
CNBC

GSK opens option of consumer division

Sir Andrew stressed there was a strong case for keeping the consumer business attached to the broader group because of synergies between pharmaceuticals and over-the-counter drugs, particularly in emerging markets where the categories are especially ...
 CNBC2 days ago MEDIA-GSK opens issue of spinning off consumer division -FT  London South East3 days ago Monday Papers: GSK opens issue of spinning off consumer division  Citywire2 days ago GSK opens issue of spinning off consumer division  FirstWord Pharma3 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less